🔎 Trials Near Me

Beranda › Kanker Metastatik › Missouri › Kansas City

Uji klinis Kanker Metastatik di Kansas City, MO

15 studi untuk Kanker Metastatik mencari peserta di lokasi sekitar Kansas City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Menerima pesertaFase 1
  • St. Lukes Hospital of Kansas City, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

Menerima pesertaFase 1
  • University of Kansas Medical Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05382559

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Menerima pesertaFase 1
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05803382

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Kansas Medical Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05875168

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Menerima pesertaFase 2/3
  • Premier Imaging, Kansas City
  • St. Joseph Medical Center, Kansas City
  • MidAmerica Cancer Care - American Oncology Partners, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Menerima pesertaFase 1
  • The University of Kansas Medical Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06915753

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Menerima pesertaFase 3
  • HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Menerima pesertaFase 3
  • Saint Luke's Cancer Institute, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07174336

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • The University of Kansas Cancer Center - Westwood, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Menerima pesertaFase 1/2
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT05691491

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Menerima pesertaFase 3
  • University of Kansas Cancer Center - North, Kansas City
  • University of Kansas Cancer Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06216301

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Menerima pesertaFase 3
  • Saint Luke's Cancer Institute, Kansas City
  • The University of Kansas Cancer Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT06757634

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Menerima pesertaFase 2/3
  • MidAmerica Cancer Care, Kansas City
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT06697301

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Menerima pesertaFase 3
  • University of Kansas Cancer Center, Westwood · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06064877

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Kansas City
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Metastatik di kota lain

Studi lain di Kansas City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.